RFID
The microtransponder has multiple uses in tagging and authentication applications where small size is essential. When used in conjunction with a proprietary injector, p-Chips can be placed under the skin of small animals, such as laboratory mice, and used to track them through experiments in research and pre-clinical trials.
Bioassays
When used in conjunction with biological probes, nucleic acids or proteins, and a high-throughput analyzer, microtransponders can facilitate the detection of multiple substances in a single biological sample. This is known as a “multiplex” assay and has been demonstrated in a diagnostic test that detects fifty different mutations related to cystic fibrosis, a major genetic disease.
PharmaSeq has a number of patents and patents pending related to microtransponder technology. PharmaSeq is privately held and based near Princeton, NJ.
See Us
Meet a PharmaSeq representative at the following conferences:
- American Association for Laboratory Animal Science (AALAS) Tri-Branch Symposium, June 13-15, 2011, Atlantic City Convention Center, Atlantic City, New Jersey.
- RFID Europe 2011, September 27-28, 2011, Churchill College, Cambridge, UK.
- American Association for Laboratory Animal Science (AALAS), 62nd National Meeting, October 2-6, 2011. San Diego, California.
Press Releases
NIH funds Tagging of Histopathology Specimens at PharmaSeq (2/1/11)
PharmaSeq Receives Phase II SBIR Grant for Small Animal Tagging (9/20/10)
PharmaSeq Receives Government Grant to Develop Nanotechnology-based Protein Multiplex Assay for Prostate Cancer (8/20/10)
PharmaSeq to Deliver Talk at International RFID Conference (8/2/10)
read more...